Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL170P is a processed pseudogene derived from the 7SL RNA gene. Pseudogenes are genomic elements that resemble functional genes but generally lack coding capacity or canonical biological activity[3][6]. The functional 7SL RNA is a non-coding RNA essential for the signal recognition particle (SRP) assembly, mediating the targeting of nascent secretory and membrane proteins to the endoplasmic reticulum[1][5][7]. However, pseudogenes, including RN7SL170P, typically do not encode functional RNAs or proteins and are not recognized receptors, enzymes, or drug targets. While there is growing evidence that some pseudogenes play roles in gene regulation or disease by acting as miRNA sponges or through epigenetic effects, RN7SL170P has not been implicated in these processes[4][6]. RN7SL170P is not a receptor, enzyme, transporter, or drug target. It is a member of the pseudogene and non-coding RNA families, similar in sequence to RN7SL1 (functional 7SL RNA). It does not appear in clinical, pharmacological, or disease databases as a therapeutic target, biomarker, or safety concern. Its main scientific relevance is as a molecular record of evolutionary gene duplication, not as a functional molecule. If you require structured information for computational analysis or drug targeting, RN7SL170P should be excluded from therapeutic target lists and handled as a pseudogene placeholder.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 170, pseudogene (RN7SL170P).